How many doses make a difference?: An analysis of secondary prevention of rheumatic fever and rheumatic heart disease
Journal of the American Heart Association Dec 15, 2018
de Dassel JL, et al. - Researchers used nested case–control and case–crossover designs as well as logistic regression to determine factors related to adherence (percent of doses administered), and the link between adherence and acute rheumatic fever (ARF) recurrence, progression to rheumatic heart disease, worsening or improvement of rheumatic heart disease, and mortality, by analyzing data from northern Australia. For the first time, it was shown in this study that increased adherence to penicillin prophylaxis led to attenuated ARF recurrence, and a possible mortality reduction. The factors that showed relation to higher adherence included being female, younger, having more-severe disease, and living remotely. A lower adherence was seen among those who misused alcohol. No decrease in the risk of ARF recurrence was seen until ≈40% of doses had been administered. A 4-fold increase in the odds of ARF recurrence was observed in association with receiving <80%, which also appeared to be associated with increased all-cause mortality.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries